Lauren Santye, Assistant Editor

New MS diagnoses are steadily on the rise.

Scientists discover a metabolic weakness in advanced breast cancer cells.

High genomic copy loss correlated with metastatic melanoma’s ability to thwart the success of immune checkpoint inhibitors.

Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Lessening approval standards could cause unproven and potentially harmful drugs to flood the marketplace.

New Alexa skill helps spread MS education and awareness.

Brain scans could help diagnose patients with HIV-related cognitive issues.

Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.

Archival tumor tissue reliably identifies patients with folate receptor alpha-positive ovarian cancer.

Ribociclib plus letrozole shows improved survival in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2) advanced or metastatic breast cancer.

Ribociclib plus letrozole improved progression free survival in patients with HR+/HER2 advanced or metastatic breast cancer.

Top news of the day from across the health care landscape.

New National Association of Specialty Pharmacy executive director discusses potential changes to the specialty pharmacy landscape.

Novel drug well-tolerated in patients with active RA who were refractory.

BET-inhibitors and immune-based treatments may improve outcomes in patients with blood cancer.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.

Fatigue and limitations in leg function may increase progress from relapsing-remitting MS to secondary progressive MS in older adults.

Melanoma survivors more likely to limit sun exposure than individuals without a history of skin cancer.

Top news of the day from across the health care landscape.

Genital herpes is associated with increased risk of HIV transmission.

Target may lead to the development of new drugs that inhibit cancer.

Top articles of the week on Specialty Pharmacy Times.

A regulatory protein that weakens the immune response to viral RNA presents a new treatment target for cancer.

Extracellular matrix receptors shield cancer cells from harsh environments.

Targeting the immune response to cancer may lead to new immunotherapies.

Non-inferiority found between tenofovir disoproxil fumarate and tenofovir alafenamide regimens.

Regimens with Descovy show non-inferiority to those containing Truvada.

Top news of the day across the health care landscape.